Core IM
There are current knowledge gaps in the evaluation of patients with nephrotic syndrome. Physicians often feel overwhelmed by the myriad of causes of nephrotic syndrome and unempowered to send first-pass workup for the syndrome. Similarly, clear indications for a kidney biopsy can appear elusive at times. In this episode of Core IM, the team discusses this challenge and explores the many management strategies for nephrotic syndrome that may appear to be anecdotal and based on presumed mechanism rather than proven by evidence-based medicine.
First, listen to the podcast. After listening, ACP members can take the CME/MOC quiz for free.
CME/MOC:
Up to 0.75
AMA PRA Category 1 Credits ™ and MOC Points
Expires September 02, 2023
expired
Cost:
Free to Members
Format:
Podcasts and Audio Content
Product:
Core IM
Welcome to Core IM, a virtual medical community! Core IM strives to empower its colleagues of all levels and backgrounds with clinically applicable information as well as inspire curiosity and critical thinking. Core IM promotes its mission through podcasts and other multimodal dialogues. ACP has teamed up with Core IM to offer continuing medical education, available exclusively to ACP members by completing the CME/MOC quiz.

- Pearl 1: Don’t be fooled by the UA!
- Review of urine dipstick vs. UA
- urine dipstick: done at bedside, not looked at under microscope but rough sense of protein, blood, pH, spec grav, LE/nitrites, ketones, glucose, bili
- UA: done in lab, microscopic exam of WBCs, RBCs, casts, crystals
- Don’t brush off +1 protein or “few” RBCs
- despite some evidence for the contrary, anecdotally, nephrologists and primary care physicians alike have been fooled by the dipstick before
- Don’t ignore the specific gravity
- concentrated urine may falsely elevate proteinuria and vice versa
- Follow-up with a UPCR
- UPCR most inclusive and includes non-albumin proteins, such as myeloma proteins
- however, UACR may be a little more sensitive than the UPCR
- Review of urine dipstick vs. UA
- Pearl 2: Key questions to ask a patient with new nephrotic syndrome/1.73m2 body surface area
- Defining nephrotic syndrome:
- nephrotic-range proteinuria: ≥3.5 g/d proteinuria
- nephrotic syndrome: nephrotic-range proteinuria with low albumin and edema/anasarca ± hyperlipidemia, thromboses
- Framework: can approach questioning from different subtypes, which is defined by extent and pattern of injury to the podocyte
- minimal change disease (MCD): so “minimal” that podocyte effacement can only be seen on electron microscopy
- Common causes: Idiopathic, NSAIDs, Hodgkin lymphoma
- focal segmental glomerulosclerosis (FSGS): focal and segmental scarring, can be thought of as more severe MCD (on a spectrum)
- causes: chronic illnesses (obesity, DM, HTN), viruses (HIV, parvovirus, SARS-CoV-2), hereditary, drugs (bisphosphonates, heroin)
- in many of the chronic illnesses, there is hyperfiltration-related injury leading to FSGS
- causes: chronic illnesses (obesity, DM, HTN), viruses (HIV, parvovirus, SARS-CoV-2), hereditary, drugs (bisphosphonates, heroin)
- membranous nephropathy: circulating antibody or other unidentified toxin causes epithelial and surrounding podocyte damage
- causes: PLA2R antibody, HBV, syphilis, lupus, cancers
- other: amyloidosis, preeclampsia, diabetes (arguably most common cause of nephrotic range proteinuria)
- minimal change disease (MCD): so “minimal” that podocyte effacement can only be seen on electron microscopy
- Summary: ask about chronic illnesses, cancer screening, viral infections and STIs, drugs, and family history
- Defining nephrotic syndrome:
- Pearl 3: What a generalist needs to know about a kidney biopsy
- Who should we biopsy?
- most patients with nephrotic syndrome and no clear cause; specifically, experts cite proteinuria >1 g/d on multiple visits without clear comorbidities and >3 g/d without diabetes as two specific scenarios, with a third scenario being…
- diabetes that appears atypical
- rapid increase in proteinuria
- diabetic nephropathy without retinopathy
- diabetic nephropathy seemingly out of proportion to diabetic control and/or duration.
- minimal change disease refractory to treatment
- could represent missed FSGS
- generally, 10-20 glomeruli on biopsy is adequate for FSGS diagnosis, but occasionally will be missed if all 20 of those happen to miss sclerotic lesions
- Are kidney biopsies safe?
- kidney biopsies are relatively safe, with bleeding observed in <1% of biopsies
- biopsies may be made safer by controlling blood pressure, holding anticoagulants, holding pressure, pre-biopsy dialysis to lower “uremic” platelet dysfunction
- expert comment: let the proceduralists talk about the risks!
- Who should we biopsy?
- Pearl 4: Practical management of the edematous state
- use higher doses of diuretics
- higher doses of loop diuretics are needed given hypoalbuminemia
- oral Lasix least bioavailable, so can start with an IV agent to bypass gut edema
- hearing loss appears to be rare and is reversible
- do not need to routine give with albumin; there are some short-term effects that do not affect long-term outcomes
- recommend a food diary to help with food restriction
- this practical handout can help patients choose which foods to eat
- use higher doses of diuretics
- Pearl 5: Nephrotic Syndrome and risk of thrombosis
- Patients with membranous nephropathy have been shown to be at increased risk for thrombotic events
- Prophylactic anticoagulation is recommended in pts with membranous nephropathy and severe hypoalbuminemia (albumin <2.5)
- Current use of warfarin and heparin, not DOAC given lack of studies
- Of note, no RCTs that have studied if patients with nephrotic syndrome benefit from anticoagulation
Contributors
Shreya Trivedi, MD - Author, Producer
Martin Fried, MD - Author, Producer
Clem Lee, MD - Author, Producer
Samira Farouk, MD - Guest Expert
Matthew Sparks, MD - Guest Expert
Reviewers
Swapnil Hiremath, MD, MPH
Gerren Hobby, MD
Tejas Patel, MD, FACP, FASN
Those named above unless otherwise indicated have no relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients.
Release Date: September 2, 2020
Expiration Date: September 2, 2023
CME Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Physicians and the Core IM. The American College of Physicians is accredited by the ACCME to provide continuing medical education for physicians.
The American College of Physicians designates each enduring material (podcast) for 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM Maintenance of Certification (MOC) Points
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 medical knowledge MOC Point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
How to Claim CME Credit and MOC Points
After listening to the podcast, complete a brief multiple-choice question quiz. To claim CME credit and MOC points you must achieve a minimum passing score of 66%. You may take the quiz multiple times to achieve a passing score.